How Value Investors Can Evaluate Bio-Tech Companies [VIDEO]

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

Value investors are well aware that investing in technology companies is not an easy task. Additionally, valuing bio-tech companies is far more difficult. The Manual of Ideas conducted an interview with Humphrey Nokes of Cygna Negra, on this very topic. Nokes discusses how value investors can evaluate bio-tech companies in this video interview:

Editor

Latest News

image of pipes for ASX copper stocks guide

Investing

Fueled by Tariff Threats, Copper Prices Hit All-Time High

Dave Kovaleski43 minutes

There are several stocks and ETFs that focus on copper investments. Copper prices have been skyrocketing this year, fueled in part by the threats of higher tariffs. And with new...